Drugs / BG-C477
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06596473 | Oct 2024 → Dec 2027 expected | cancer | BeOne Medicines | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BG-C477 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06596473 ↗ |
| Route | Intravenous | “Administered intravenously.” NCT06596473 ↗ |